{"title":"脑出血的超急性医学处理","authors":"Allan Paterson, A. Parry-Jones","doi":"10.47795/ziui6736","DOIUrl":null,"url":null,"abstract":"Intracerebral haemorrhage (ICH) is caused by spontaneous, non-traumatic haemorrhage within the brain parenchyma. ICH has poor outcomes, with a 30-40% 1-month case fatality and most survivors remaining dependent. Current management of ICH is aimed at providing appropriate supportive care and reducing the risk of haematoma expansion, which affects up to 20-30% of patients in the first 24 hours. Rapid and intensive blood pressure lowering to a pre-specified target and reversal of anticoagulants in the 20% of patients who are taking them may reduce the risk of expansion and improve outcome.","PeriodicalId":34274,"journal":{"name":"Advances in Clinical Neuroscience Rehabilitation","volume":"22 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Hyperacute Medical Management of Intracerebral Haemorrhage\",\"authors\":\"Allan Paterson, A. Parry-Jones\",\"doi\":\"10.47795/ziui6736\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Intracerebral haemorrhage (ICH) is caused by spontaneous, non-traumatic haemorrhage within the brain parenchyma. ICH has poor outcomes, with a 30-40% 1-month case fatality and most survivors remaining dependent. Current management of ICH is aimed at providing appropriate supportive care and reducing the risk of haematoma expansion, which affects up to 20-30% of patients in the first 24 hours. Rapid and intensive blood pressure lowering to a pre-specified target and reversal of anticoagulants in the 20% of patients who are taking them may reduce the risk of expansion and improve outcome.\",\"PeriodicalId\":34274,\"journal\":{\"name\":\"Advances in Clinical Neuroscience Rehabilitation\",\"volume\":\"22 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advances in Clinical Neuroscience Rehabilitation\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.47795/ziui6736\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Clinical Neuroscience Rehabilitation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47795/ziui6736","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Hyperacute Medical Management of Intracerebral Haemorrhage
Intracerebral haemorrhage (ICH) is caused by spontaneous, non-traumatic haemorrhage within the brain parenchyma. ICH has poor outcomes, with a 30-40% 1-month case fatality and most survivors remaining dependent. Current management of ICH is aimed at providing appropriate supportive care and reducing the risk of haematoma expansion, which affects up to 20-30% of patients in the first 24 hours. Rapid and intensive blood pressure lowering to a pre-specified target and reversal of anticoagulants in the 20% of patients who are taking them may reduce the risk of expansion and improve outcome.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
